About ThermiGen
ThermiGen is a Healthcare company based in Austin (United States) founded in 2012, and was acquired by Celling Biosciences in March 2019. Thermistor-regulated energy systems are developed for aesthetic and dermatology uses. ThermiGen has raised $8 million across 3 funding rounds from investors including SVB, Almirall and Celling Biosciences. Its chief executive, as recorded, is Gianfranco Nazzi. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its competitors include Primaeva Medical, EndyMed and Serene Medical; 2 of its 3 listed competitors have raised funding.
Company details
ThermiGen was established in 2012 in Austin, United States, as a subsidiary of Almirall. Temperature-controlled radio frequency devices are produced for aesthetic and dermatology sectors, targeting skin tightening, excessive sweating reduction, feminine rejuvenation, and cellulite treatment. Key products include ThermiTight, ThermiVa, and ThermiSmooth, among others. FDA clearance has been obtained for the device lineup, supporting clinical applications in these fields.
- Headquarters Austin, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website thermi.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Celling Biosciences (Mar 2019)
- Total Equity Funding$8M (USD)
in 3 rounds
- Latest Funding Round$8M (USD), Series A
Sep 2015
- InvestorsSVB
& 3 more
- Acquired by
Apps and channels of ThermiGen
its YouTube channel Thermi has 616 subscribers and 16 videos.
Videos from ThermiGen
The most watched videos on ThermiGen's YouTube channel, Thermi (616 subscribers). Click a video to play it here.
More on Thermi.
Funding Insights of ThermiGen
ThermiGen has successfully raised a total of $8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 3
- Last Round Series A — $8M
- Investors Count 3
All 3 funding rounds of ThermiGen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $8M | Series A | – | Almirall | – |
| Jan 2015 | $9M | Debt – Conventional | – | – | |
| May 2013 | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in ThermiGen
ThermiGen has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Almirall and Celling Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-dilutive growth capital is provided by Cypress Growth Capital. | 2010 | cypressgrowthcapital.com | Dallas, United States | |
Generic finished formulations are manufactured and commercialized by Almirall. | 1943 | almirall.com | Barcelona, Spain | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Point-of-care autologous regenerative cell therapies are provided by clinicians. | 2013 | cellingbiosciences.com | Austin, United States |
Investor details for ThermiGen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ThermiGen
7 people are tracked at ThermiGen (2 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Gianfranco Nazzi | CEO | Leadership |
Fay Sera | Director Of Quality | Leadership |
Angela Winter Rn | Clinical Specialist And Medical Science Liaison | Team |
Chris Trammell | Technical Services Manager | Team |
Natalie Williams | Territory Sales Manager | Team |
Abigail Crowley | Marketing Manager | Team |
Charles Verhoeff | Digital Manager | Team |
Complete people profiles for ThermiGen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ThermiGen
5 dated milestones of ThermiGen across 7 years, from founding to its latest funding, stage changes and deals.
- Founded ThermiGen is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $8.0M.
- Exit Acquired by Almirall.
- Exit Acquired by Celling Biosciences.
Competitors of ThermiGen
ThermiGen has 3 listed competitors in our database, 2 of them funded. They include Primaeva Medical, EndyMed and Serene Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| primaevamedical.com | 2005 | Pleasanton, United States | $14.25M | Aesthetic treatment devices for dermatologists and cosmetic surgeons | ||
| endymed.com | 2007 | New York, United States | Radiofrequency-based systems for aesthetic skin treatments are developed. | |||
| serenemedical.com | 2010 | San Ramon, United States | $3M | Handheld device for selective modulation of target motor nerves to treat aesthetic conditions. |
Detailed competitors of ThermiGen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ThermiGen
The website of ThermiGen (thermi.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 6.5% vs previous month
Websites whose visitors overlap most with ThermiGen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zeltiq.com | 100% | View details | |||
lipodoc.com | lipodoc.com | 90% | #3,178,781 | – | |
planoaesthetics.com | planoaesthetics.com | 86% | – | ||
advanceddermatologypc.com | advanceddermatologypc.com | 84% | #595,758 | – |
Top companies in Dermatology
3 companies that operate in the same segment as ThermiGen (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Thermigen
Complete news archive for ThermiGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThermiGen
ThermiGen was founded in 2012 and raised its 1st funding round 1 year after it was founded.
ThermiGen is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Gianfranco Nazzi is the CEO of ThermiGen, as recorded in our data.
ThermiGen is a funded company, having raised a total of $8M across 3 funding rounds to date.
ThermiGen was established in 2012 in Austin, United States, as a subsidiary of Almirall. Temperature-controlled radio frequency devices are produced for aesthetic and dermatology sectors, targeting skin tightening, excessive sweating reduction, feminine rejuvenation, and cellulite treatment. Key products include ThermiTight, ThermiVa, and ThermiSmooth, among others. FDA clearance has been obtained for the device lineup, supporting clinical applications in these fields.
ThermiGen's top competitors include Primaeva Medical, EndyMed and Serene Medical.
ThermiGen has 4 investors. Key investors include SVB, Almirall, Celling Biosciences, and Cypress Growth Capital.
Yes. ThermiGen was acquired by Celling Biosciences in March 2019.